JoVE Logo

Iniciar sesión

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.

Unlike nondepolarizing blockers, succinylcholine, a depolarizing blocker, has more severe adverse effects, including hyperkalemia, arrhythmia, postoperative muscle pain, increased intraocular pressure, and regurgitation of gastric content due to increased gastric pressure.

Adverse effects of directly acting agents like botulinum toxin and dantrolene include general muscle weakness and hepatotoxicity. Additionally, botulinum toxin can cause respiratory tract infections and loss of bladder control.

Lastly, centrally acting muscle relaxants, which affect the central nervous system or CNS, induce various symptoms of CNS depression. For example, tizanidine causes drowsiness, hypotension, dizziness, dry mouth, and hepatotoxicity, whereas diazepam causes anxiety, tremors, insomnia, and hallucinations. Avoiding high drug doses from being given to at-risk patients such as epileptic patients or pregnant women may help reduce the severity of the side effects.

Tags

Skeletal Muscle RelaxantsAdverse EffectsMuscle ParalysisNondepolarizing Neuromuscular BlockersHypotensionBaclofenSpastic ConditionsSuccinylcholineHyperkalemiaArrhythmiaPostoperative Muscle PainBotulinum ToxinDantroleneCNS DepressionTizanidineDiazepamHepatotoxicity

Del capítulo 7:

article

Now Playing

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants

327 Vistas

article

7.1 : Unión neuromuscular y bloqueo

Skeletal Muscle Relaxants

2.7K Vistas

article

7.2 : Clasificación de los relajantes del músculo esquelético

Skeletal Muscle Relaxants

2.3K Vistas

article

7.3 : Bloqueadores neuromusculares no despolarizantes (competitivos): mecanismo de acción

Skeletal Muscle Relaxants

1.4K Vistas

article

7.4 : Bloqueadores neuromusculares no despolarizantes (competitivos): acciones farmacológicas

Skeletal Muscle Relaxants

380 Vistas

article

7.5 : Bloqueadores neuromusculares no despolarizantes (competitivos): farmacocinética

Skeletal Muscle Relaxants

424 Vistas

article

7.6 : Bloqueadores despolarizantes: mecanismo de acción

Skeletal Muscle Relaxants

1.1K Vistas

article

7.7 : Bloqueadores despolarizantes: farmacocinéticos

Skeletal Muscle Relaxants

299 Vistas

article

7.8 : Relajantes musculares de acción directa: Dantroleno y toxina botulínica

Skeletal Muscle Relaxants

642 Vistas

article

7.10 : Relajantes del músculo esquelético: usos terapéuticos

Skeletal Muscle Relaxants

448 Vistas

article

7.11 : Agentes espasmolíticos: clasificación química

Skeletal Muscle Relaxants

845 Vistas

article

7.12 : Relajantes musculares de acción periférica y central: una comparación

Skeletal Muscle Relaxants

3.1K Vistas

article

7.13 : Relajantes musculares de acción central: usos terapéuticos

Skeletal Muscle Relaxants

599 Vistas

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados